Qin, Y.; Mo, Y.; Li, P.; Liang, X.; Yu, J.; Chen, D.
Early Immune Checkpoint Inhibitor Administration Increases the Risk of Radiation-Induced Pneumonitis in Patients with Stage III Unresectable NSCLC Undergoing Chemoradiotherapy. Cancers 2025, 17, 1711.
https://doi.org/10.3390/cancers17101711
AMA Style
Qin Y, Mo Y, Li P, Liang X, Yu J, Chen D.
Early Immune Checkpoint Inhibitor Administration Increases the Risk of Radiation-Induced Pneumonitis in Patients with Stage III Unresectable NSCLC Undergoing Chemoradiotherapy. Cancers. 2025; 17(10):1711.
https://doi.org/10.3390/cancers17101711
Chicago/Turabian Style
Qin, Yiwei, You Mo, Pengwei Li, Xinyi Liang, Jinming Yu, and Dawei Chen.
2025. "Early Immune Checkpoint Inhibitor Administration Increases the Risk of Radiation-Induced Pneumonitis in Patients with Stage III Unresectable NSCLC Undergoing Chemoradiotherapy" Cancers 17, no. 10: 1711.
https://doi.org/10.3390/cancers17101711
APA Style
Qin, Y., Mo, Y., Li, P., Liang, X., Yu, J., & Chen, D.
(2025). Early Immune Checkpoint Inhibitor Administration Increases the Risk of Radiation-Induced Pneumonitis in Patients with Stage III Unresectable NSCLC Undergoing Chemoradiotherapy. Cancers, 17(10), 1711.
https://doi.org/10.3390/cancers17101711
